Sagimet Biosciences Inc
F:0O2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sagimet Biosciences Inc
F:0O2
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
M
|
Medifast Inc
DUS:MDF
|
US |
|
Taboola.com Ltd
F:1FY
|
US |
|
A
|
Aptiv PLC
XMUN:D7A
|
IE |
|
Acme United Corp
F:UT1
|
US |
Wall St Price Targets
0O2 Price Targets Summary
Sagimet Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
0O2 is 21.4 EUR with a low forecast of 6.43 EUR and a high forecast of 40.95 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0O2's stock price target?
Price Target
21.4
EUR
According to Wall Street analysts, the average 1-year price target for
0O2 is 21.4 EUR with a low forecast of 6.43 EUR and a high forecast of 40.95 EUR.